The US Naval Medical Logistics Command (NMLC) has awarded a contract to Leidos to support operational medicine research to enhance warfighter readiness.

The single award indefinite delivery, indefinite quantity contract is valued at a maximum of $82m and includes a 60-month performance period.

Under the contract, Leidos will carry out operational medicine and warfighter performance research for the Operational Readiness Directorate of the Naval Health Research Center (NHRC).

The company will conduct the work primarily at NHRC in San Diego, California.

Leidos Health Group president Liz Porter said: “We are excited to continue our support of the Naval Health Research Center.

“Through this contract, Leidos will utilise our robust scientific and technical expertise to support important NHRC research.

“We are proud to do our part to improve lives and ensure our military personnel can perform at the highest levels.”

NHRC carries out core research regarding operational readiness, military health and infectious diseases.

Under the operational readiness area, NHRC uses breakthroughs for the optimisation of human performance, recovery, and resilience, as well as to avoid injuries.

Additionally, it is involved in the development of medical planning, logistics and decision support tools for the armed forces.

Leidos will continue to offer data-driven research modelling to aid operational medicine.

According to the company, the modelling is expected to boost the medical decision tools used by operational commanders, medical logisticians, and field medical personnel.

In January last year, Leidos obtained a contract from the US NMLC to provide research support services at its NHRC.